This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Pool Corp, Clorox, T-Mobile and Activision Blizzard highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Pool Corp, Clorox, T-Mobile and Activision Blizzard highlighted as Zacks Bull and Bear of the Day
Bear of the Day: Clorox (CLX)
by Tracey Ryniec
Rising costs are a problem for this former pandemic winner.
Company News for May 3, 2021
by Zacks Equity Research
Companies In The News Are: AON, ALXN, CLX, QSR.
Clorox (CLX) Q3 Earnings Beat & Sales Miss, FY21 View Updated
by Zacks Equity Research
Clorox's (CLX) third-quarter fiscal 2021 earnings beat estimates but declined year over year on lower gross margins and increased advertising investments.
Stimmy Checks Bring Record Personal Income: +21.1%
by Mark Vickery
These figures reach all the way back to 1959, and only twice before has this monthly read ever gotten above 10%.
Consumer Spending Increased in March
by Zacks Equity Research
Consumer Spending Increased in March
Clorox (CLX) Tops Q3 Earnings Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 10.20% and -4.69%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Consumer Staples Stock Earnings to Watch on Apr 30: CLX, CL, NWL
by Rajani Lohia
Consumer Staples stocks' results are expected to reflect gains from strong demand for home essentials and food items, though in moderation from the last year. Elevated costs are likely to have hurt.
Clorox (CLX) Queues Up For Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Clorox (CLX) witnesses manufacturing and logistics costs. These along with higher selling and administrative costs might have hurt the bottom line in third-quarter fiscal 2021.
3 Soaps & Cleaning Stocks That are Braving Industry Challenges
by Vidya Nair
Pandemic-led rise in input costs are a headwind for several soap and cleaning materials companies. Nonetheless, strong demand for personal care items is a boon for players like Procter & Gamble (PG), Unilever (UL) and Church & Dwight (CHD).
Clorox (CLX) Q2 Earnings, Sales Top Estimates on Strong Demand
by Zacks Equity Research
Clorox's (CLX) Q2 sales benefit from double-digit sales growth in the majority of the segments, fueled by strong product demand due to the coronavirus outbreak and related shift in trends.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge
Jobless Claims Fall to 779K; Q4 Productivity -4.8%
by Mark Vickery
Initial Jobless Claims fell to 779K last week, a welcome change from the 900K+ we had begun to see a couple weeks ago.
Clorox (CLX) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 17.34% and 4.30%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Estee Lauder (EL) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Soft store traffic stemming from coronavirus-induced restrictions on travel and consumer health concerns are likely to get reflected in Estee Lauder's (EL) second-quarter fiscal 2021 performance.
Is Clorox (CLX) Likely to Report a Beat in Q2 Earnings?
by Zacks Equity Research
Clorox's (CLX) Q2 performance is likely to have benefited from the pandemic-led cleaning frenzy among consumers, which has led to escalated demand for cleaning products.
Clorox (CLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Clorox (CLX) Up More Than 23% in a Year: What You Should Know
by Zacks Equity Research
Clorox's (CLX) IGNITE strategy, which targets boosting overall growth, bodes well. Notably, the company's cost-savings program is significantly contributing to gross margin expansion.
Clorox (CLX) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed the most recent trading day at $197.84, moving +0.72% from the previous trading session.
Why Clorox (CLX) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Clorox (CLX) Stock Moves -0.35%: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed the most recent trading day at $202.45, moving -0.35% from the previous trading session.
Clorox (CLX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed at $202.38 in the latest trading session, marking a +0.22% move from the prior day.
Clorox (CLX) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed at $200.51 in the latest trading session, marking a -1.17% move from the prior day.
5 Soaps & Cleaning Products Stocks Worth a Look Amid Coronavirus Woes
by Vidya Nair
The COVID-led rising demand for hygiene products is a boon for several soap and cleaning materials companies such as Procter & Gamble (PG), Unilever (UL), Colgate (CL), Clorox (CLX) and Church & Dwight (CHD), However, rising input costs are a concern.
Why Is Clorox (CLX) Down 4.3% Since Last Earnings Report?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.